JPRN-UMIN000018755
Completed
未知
A clinical study for evaluating the efficacy of the highly-concentrated oxygen nanobubble water -immune function, fatigue, autonomic nervous function and skin function- - A clinical study for evaluating the efficacy of the highly-concentrated oxygen nanobubble water
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Soiken Inc.
- Enrollment
- 17
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Subject receiving a medical treatment for serious renal, hepatic, cardio\-vascular, respiratory, endocrine or metabolic disorders or having a medical history of these disorders 2\) Subject having the chronic fatigue syndrome(CFS) , or subject deemed to have severe fatigue like idiopathic chronic fatigue by the investigator 3\) Subject having a medical history of chest pain or syncope 4\) Subject having an abnormality in the electrocardiogram 5\)Subject having a subjective symptom of low back pain, arthralgia or lumber hernia, disease of lower limbs, palpitations 6\)Subjects who take regularly medical supplies or quasi\-drugs which having the efficacy on recovery of fatigue or nutrition disorder at physical fatigue 7\) Subjects who take regularly the highly\-concentrated oxygen water 8\) Subject having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 9\)Subject who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 10\)Female subjects who is pregnant or lactating, or intending to become pregnant during the study 11\)Subject deemed unsuitable by the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Hair Benefit Study For The Ayurvedic Proprietary MedicineCTRI/2023/06/053922Hindustan Unilever Ltd216
Not yet recruiting
Phase 3
Shirishadi Malhar & Parushakadi Yog in the Management of KIKKISA w.s.r. to STRIAE GRAVIDARUMHealth Condition 1: L929- Granulomatous disorder of the skinand subcutaneous tissue, unspecifiedHealth Condition 2: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhereCTRI/2023/07/055029Government of Himachal Pradesh
Completed
Not Applicable
A clinical study for evaluating the efficacy of test food on the suppression of the elevation of postprandial blood glucose level. -Randomised double-blind placebo-controlled trialHealthy adultJPRN-UMIN000035336KSO Corporation50
Completed
Not Applicable
A clinical study for evaluating the efficacy of test food on the suppression of the elevation of postprandial blood glucose levelHealthy adultJPRN-UMIN000043321Pharma Foods International Co., Ltd.30
Completed
Not Applicable
A clinical study for evaluating the efficacy of test food on the suppression of the elevation of postprandial serum triglyceride. : Randomised double-blind placebo-controlled trialHealthy adultJPRN-UMIN000036241Allegro Inc.30